532612 Stock Overview
Manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Indoco Remedies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹239.25 |
| 52 Week High | ₹385.50 |
| 52 Week Low | ₹190.00 |
| Beta | 0.39 |
| 1 Month Change | 3.82% |
| 3 Month Change | -28.51% |
| 1 Year Change | -28.03% |
| 3 Year Change | -37.06% |
| 5 Year Change | 0.36% |
| Change since IPO | 353.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532612 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 6.1% | 6.4% | 6.5% |
| 1Y | -28.0% | 14.6% | 3.6% |
Return vs Industry: 532612 underperformed the Indian Pharmaceuticals industry which returned 12.9% over the past year.
Return vs Market: 532612 underperformed the Indian Market which returned 2.1% over the past year.
Price Volatility
| 532612 volatility | |
|---|---|
| 532612 Average Weekly Movement | 9.6% |
| Pharmaceuticals Industry Average Movement | 7.5% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in IN Market | 9.9% |
| 10% least volatile stocks in IN Market | 4.9% |
Stable Share Price: 532612's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 532612's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1945 | 6,000 | Sundeep Bambolkar | www.indoco.com |
Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. It offers stomatological, gastrointestinal, respiratory, anti-infectives, vitamins/minerals/nutrients, ophthal/ontological, dermatology, urological, anti-diabetic, gynaecological, lifestyle management, pain/analgesic, and cardiac products. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, as well as anti-haemorrhoidal creas and calcium preparations.
Indoco Remedies Limited Fundamentals Summary
| 532612 fundamental statistics | |
|---|---|
| Market cap | ₹22.13b |
| Earnings (TTM) | -₹106.60m |
| Revenue (TTM) | ₹17.24b |
1.3x
P/S Ratio-207.6x
P/E RatioIs 532612 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532612 income statement (TTM) | |
|---|---|
| Revenue | ₹17.24b |
| Cost of Revenue | ₹5.94b |
| Gross Profit | ₹11.30b |
| Other Expenses | ₹11.41b |
| Earnings | -₹106.60m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.16 |
| Gross Margin | 65.54% |
| Net Profit Margin | -0.62% |
| Debt/Equity Ratio | 76.6% |
How did 532612 perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield14%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/17 11:08 |
| End of Day Share Price | 2025/04/17 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Indoco Remedies Limited is covered by 17 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sriraam Rathi | Anand Rathi Shares and Stock Brokers Limited |
| Sarabjit Nangra | Angel Broking Private Limited |
| Srivathsan Ramachandran | Avendus Spark |